← Return to Areas of Focus

 

FOCUS AREA 1

Treatment Access

Objective 1-1: By January 2018, establish a pilot coordinated entry system to process and coordinate SUD treatment referrals

A coordinated entry system for SUD provides a single point of contact for any community-based substance misuse referral. This means that medical providers, law enforcement, community organizations, and others will be able to make referrals through one entry point utilizing universal procedures. A coordinated entry system is a unified and universal referral system for the community and helps to integrate primary and behavioral healthcare systems by providing a more streamlined access point for referrals by primary care providers. It also enhances a balanced public health / public safety approach by providing opportunities for entities from both fields to work together toward overlapping objectives.

RELATED FOCUS AREAS: Prescriber Education, Data Informed Decision Making, Prevention and Public Education, Pharmacy-based Interventions, Support Law Enforcement and First Responders
NEEDS ADDRESSED: Data, Prevention Activities, Training and Education, Reduce Stigma, Improvement Treatment Capacity, Policy Coordination
LEAD AGENCY PARTNERS: DOH, Alcohol and Drug Abuse Division (ADAD), Hawaii Substance Abuse Coalition (HSCAC)

ON TARGET

A pilot has been funded through the Hawaii Screening, Brief Intervention and Referral to Treatment (SBIRT) grant and is set to begin accepting referrals from SBIRT providers in December 2017.

Objective 1-2: By October 2017, all ADAD contracted substance misuse providers will be eligible to bill MAT services in both outpatient and inpatient settings.

The number of Opioid Treatment Programs and Office-Based Opioid Treatment entitities are limited in Hawaii. This objective is designed to assure sufficient capacity is maintained to fill the need for treating individuals with OUDs. The State will utilize the procurement process to expand the scope and capacity of OUD services by including language in its treatment contracts to that effect.

RELATED FOCUS AREAS: Prescriber Education, Data Informed Decision Making, Prevention and Public Education, Pharmacy-based Interventions
NEEDS ADDRESSED: Data, Reduce Stigma, Improvement Treatment Capacity, Policy Coordination
LEAD AGENCY PARTNERS: DOH, Alcohol and Drug Abuse Division (ADAD)

COMPLETED

ADAD treatment contracts have been executed to include the ability for all treatment providers to utilize a MAT billing component, provided they meet one of the two criteria noted in the report.

Objective 1-3: By December 2018, increase the number of prescribers licensed to prescribe and administer Medication-Assisted Treatment ()MAT) such as buprenorphine and Suboxone by 25%.

The number of providers who are licensed to provide medication-assisted treatment is limited in Hawaii. This goal is designed to assure sufficient capacity is maintained to fill the need for treating individuals with OUDs. ADAD will develop and provide quarterly DATA waiver training sessions necessary for providers to obtain authorization to provide MAT. This objective will be coordinated with the Hawaii SBIRT project to leverage contracts with Independent Physician Associations and healthcare centers to assist with training and technical assistance for member providers.

RELATED FOCUS AREAS: Prescriber Education, Treatment Access, Prevention and Public Education, Pharmacy-based Interventions
NEEDS ADDRESSED: Data, Prevention Activities, Training and Education, Reduce Stigma, Improvement Treatment Capacity, Policy Coordination
LEAD AGENCY PARTNERS: DOH, Alcohol and Drug Abuse Division (ADAD)

PENDING

ADAD will develop training in 2018.